{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:38:48Z","timestamp":1790249928530,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.humimm.2020.01.002","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T18:04:50Z","timestamp":1578593090000},"page":"134-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["HLA-G +3196 polymorphism as a risk factor for cell mediated rejection following heart transplant"],"prefix":"10.1016","volume":"81","author":[{"given":"Mitchell B.","family":"Adamson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bennett","family":"Di Giovanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto V.P.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Lazarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego H.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2020.01.002_b0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The registry of the international society for heart and lung transplantation: thirty-fourth adult heart transplantation report-2017; focus theme: allograft ischemic time","volume":"36","author":"Lund","year":"2017","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","article-title":"Mechanism of cellular rejection in transplantation","volume":"25","author":"Ingulli","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.humimm.2020.01.002_b0015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.healun.2011.02.015","article-title":"The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005\u20132011)","volume":"30","author":"Berry","year":"2011","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0020","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.healun.2005.03.018","article-title":"The revised ISHLT heart biopsy grading scale","volume":"24","author":"Billingham","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.healun.2008.02.004","article-title":"Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients","volume":"27","author":"Sheshgiri","year":"2008","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0035","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/eji.200425741","article-title":"Tolerization of dendritic cells by HLA-G","volume":"35","author":"Ristich","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00251-018-1058-2","article-title":"HLA-G peptide preferences change in transformed cells: impact on the binding motif","volume":"70","author":"Celik","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2020.01.002_b0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.healun.2011.01.726","article-title":"The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients","volume":"30","author":"Twito","year":"2011","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0050","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.healun.2016.04.014","article-title":"Human leukocyte antigen G single-nucleotide polymorphism -201 (CC-CC) donor-recipient genotype matching as a predictor of severe cardiac allograft vasculopathy","volume":"35","author":"Lazarte","year":"2016","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-2776(03)81006-4","article-title":"HLA-G molecules: from maternal-fetal tolerance to tissue acceptance","volume":"81","author":"Carosella","year":"2003","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0060","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.humimm.2003.08.356","article-title":"Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients","volume":"64","author":"Creput","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/tan.12210","article-title":"Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease","volume":"82","author":"Misra","year":"2013","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.01.002_b0070","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.healun.2005.03.019","article-title":"Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection","volume":"24","author":"Stewart","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0075","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1016\/j.healun.2005.04.001","article-title":"Nodular endocardial infiltrates (Quilty lesions) cause significant variability in diagnosis of ISHLT Grade 2 and 3A rejection in cardiac allograft recipients","volume":"24","author":"Marboe","year":"2005","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-0039.2008.01107.x","article-title":"The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma","volume":"72","author":"Chen","year":"2008","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.01.002_b0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/ahg.12114","article-title":"Analysis of human triallelic SNPs by next-generation sequencing","volume":"79","author":"Cao","year":"2015","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.humimm.2020.01.002_b0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.humimm.2018.05.003","article-title":"10-Year experience with HLA-G in heart transplantation","volume":"79","author":"Lazarte","year":"2018","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/814182","article-title":"HLA-G polymorphism (rs16375) and acute rejection in liver transplant recipients","volume":"2014","author":"Azarpira","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.humimm.2020.01.002_b0100","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.4049\/jimmunol.176.3.1331","article-title":"Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes","volume":"176","author":"Bahri","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/gene.2009.74","article-title":"The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes","volume":"11","author":"Castelli","year":"2010","journal-title":"Genes Immun."},{"key":"10.1016\/j.humimm.2020.01.002_b0110","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/molbev\/msr138","article-title":"A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution","volume":"28","author":"Castelli","year":"2011","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.humimm.2020.01.002_b0115","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2014.00476","article-title":"Insights into HLA-G genetics provided by worldwide haplotype diversity","volume":"5","author":"Castelli","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","article-title":"HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels","volume":"55","author":"Hviid","year":"2003","journal-title":"Immunogenetics"},{"key":"10.1016\/j.humimm.2020.01.002_b0125","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nrg1125","article-title":"The power of the 3' UTR: translational control and development","volume":"4","author":"Kuersten","year":"2003","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.humimm.2020.01.002_b0130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.humimm.2009.07.028","article-title":"In silico analysis of microRNAS targeting the HLA-G 3 ' untranslated region alleles and haplotypes","volume":"70","author":"Castelli","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0135","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/734068","article-title":"Transcriptional and posttranscriptional regulations of the HLA-G gene","volume":"2014","author":"Castelli","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2020.01.002_b0140","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.humimm.2003.08.347","article-title":"The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability","volume":"64","author":"Rousseau","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.humimm.2006.11.008","article-title":"Mechanisms of prolongation of allograft survival by HLA-G\/ILT4-modified dendritic cells","volume":"68","author":"Ristich","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0150","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2013.095281","article-title":"HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphism","volume":"99","author":"Rizzo","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.humimm.2020.01.002_b0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/425244a","article-title":"Molecular biology \u2013 MicroRNA is here to stay","volume":"425","author":"Benfey","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2020.01.002_b0160","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.rbmo.2012.06.022","article-title":"Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression","volume":"25","author":"Wang","year":"2012","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.humimm.2020.01.002_b0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082517","article-title":"HLA-G UTR haplotype conservation in the Malian population: association with soluble HLA-G","volume":"8","author":"Carlini","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.humimm.2020.01.002_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.meegid.2013.03.004","article-title":"HLA-G 3' UTR-2 haplotype is associated with Human African trypanosomiasis susceptibility","volume":"17","author":"Courtin","year":"2013","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.humimm.2020.01.002_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1034\/j.1399-0039.2001.057001015.x","article-title":"Association of soluble HLA-G plasma levels with HLA-G alleles","volume":"57","author":"Rebmann","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.humimm.2020.01.002_b0180","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.13305","article-title":"HLA-G*01:04 approximately UTR3 recipient correlates with lower survival and higher frequency of chronic rejection after lung transplantation","author":"Di Cristofaro","year":"2015","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2020.01.002_b0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.humimm.2012.10.027","article-title":"HLA-G haplotype structure shows good conservation between different populations and good correlation with high, normal and low soluble HLA-G expression","volume":"74","author":"Di Cristofaro","year":"2013","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2020.01.002_b0190","first-page":"355","article-title":"Implication of HLA-G molecule in heart-graft acceptance","author":"Lila","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.humimm.2020.01.002_b0195","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/153981","article-title":"HLA-G dimers in the prolongation of kidney allograft survival","volume":"2014","author":"Ezeakile","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2020.01.002_b0200","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-012-1069-3","article-title":"Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptors","author":"Howangyin","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.humimm.2020.01.002_b0205","doi-asserted-by":"crossref","first-page":"10439","DOI":"10.1074\/jbc.M512305200","article-title":"Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer","volume":"281","author":"Shiroishi","year":"2006","journal-title":"J. Biol. Chem."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885919313655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:52:32Z","timestamp":1759319552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885919313655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0198885919313655"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2020.01.002","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-G +3196 polymorphism as a risk factor for cell mediated rejection following heart transplant","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2020.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}